Cancer Genomics and Proteomics : Impact Factor & More
eISSN: 1790-6245pISSN: 1109-6535
Share this on:
Key Metrics
CiteScore 
6.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Genetics
SNIP
0.94
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Genomics and Proteomics
Cancer Genomics and Proteomics Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Cancer Genomics and Proteomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Genomics and Proteomics
SNRPD2-dependency Fuels an Oncogenic Alternative Splicing Repertoire Driving Disease Aggressiveness in Glioma.
- 1 Mar 2026
- Cancer genomics & proteomics
Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity.
- 1 Mar 2026
- Cancer genomics & proteomics
Decoding the Mechanisms of Hepatocellular Carcinoma Cancer Stem Cells and Identifying Potential Therapeutic Strategies Based on Single-cell Omics
- 1 Mar 2026
- Cancer Genomics & Proteomics
Splicing Factor SF3B4 Promotes Melanoma Migration via Splicing-dependent Regulation of Talin1.
- 1 Mar 2026
- Cancer genomics & proteomics
NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review.
- 1 Mar 2026
- Cancer genomics & proteomics
SNRPD2-dependency Fuels an Oncogenic Alternative Splicing Repertoire Driving Disease Aggressiveness in Glioma.
- 1 Mar 2026
- Cancer genomics & proteomics
Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity.
- 1 Mar 2026
- Cancer genomics & proteomics
Decoding the Mechanisms of Hepatocellular Carcinoma Cancer Stem Cells and Identifying Potential Therapeutic Strategies Based on Single-cell Omics
- 1 Mar 2026
- Cancer Genomics & Proteomics
Splicing Factor SF3B4 Promotes Melanoma Migration via Splicing-dependent Regulation of Talin1.
- 1 Mar 2026
- Cancer genomics & proteomics
NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer.
- 1 Mar 2026
- Cancer genomics & proteomics
Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review.
- 1 Mar 2026
- Cancer genomics & proteomics
FAQs on Cancer Genomics and Proteomics
How long has Cancer Genomics and Proteomics been actively publishing? 
What is the publishing frequency of Cancer Genomics and Proteomics?
How many articles did Cancer Genomics and Proteomics publish last year?
What is the eISSN & pISSN for Cancer Genomics and Proteomics?
What is Citescore for Cancer Genomics and Proteomics?
What is SNIP score for Cancer Genomics and Proteomics?
What is the SJR for Cancer Genomics and Proteomics?
Who is the publisher of Cancer Genomics and Proteomics?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations